Clinical risks of thrombolytic therapy

This publication has 35 references indexed in Scilit:

• Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: A risk-benefit analysis
  The American Journal of Cardiology, 1992
• Thrombolytic therapy in patients requiring cardiopulmonary resuscitation
  The American Journal of Cardiology, 1991
• Older age and elevated blood pressure are risk factors for intracerebral hemorrhage after thrombolysis
  The American Journal of Cardiology, 1991
• The use of intraaortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction
  American Heart Journal, 1991
• Effect of Intravenous Streptokinase as Compared with That of Tissue Plasminogen Activator on Left Ventricular Function after First Myocardial Infarction
  New England Journal of Medicine, 1989
• Transmission of Human Immunodeficiency Virus (HIV) by Blood Transfusions Screened as Negative for HIV Antibody
  New England Journal of Medicine, 1988
• A Randomized Trial of Intravenous Tissue Plasminogen Activator for Acute Myocardial Infarction with Subsequent Randomization to Elective Coronary Angioplasty
  New England Journal of Medicine, 1987
• Mortality and morbidity rates of patients older and younger than 75 years with acute myocardial infarction treated with intravenous streptokinase
  The American Journal of Cardiology, 1987
• Ventricular arrhythmias during reperfusion
  American Heart Journal, 1986
• The hypotensive effect of intravenous streptokinase in patients with acute myocardial infarction.
  Circulation, 1985